TORONTO, May 23, 2024 (GLOBE NEWSWIRE) — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 11, 2024 was elected as a director of the Company (a “Director”) at the annual meeting (the “Meeting”) of the holders of common shares of the Company (the “Common Shares”) held today. The number of Common Shares voted in person or by proxy for the election of each Director or withheld was as indicated below:
| Name of Nominee | Votes For | % | Votes Withheld | % |
| Heather Allen | 31,936,139 | 99.81% | 60,522 | 0.19% |
| Dr. Louis Aronne | 31,402,494 | 98.14% | 594,167 | 1.86% |
| Tania Clarke | 31,990,916 | 99.98% | 5,745 | 0.02% |
| Michael Pilato | 31,965,636 | 99.90% | 31,025 | 0.10% |
| Timothy Penner | 31,947,396 | 99.85% | 49,265 | 0.15% |
| Catherine Potechin | 31,824,717 | 99.46% | 171,944 | 0.54% |
| François Vimard | 31,989,895 | 99.98% | 6,766 | 0.02% |
| Mei Ye | 31,989,440 | 99.98% | 7,221 | 0.02% |
Final results on all matters voted at the Meeting will be filed with the Canadian securities regulatory authorities and will be available on the Company’s SEDAR+ profile at www.sedarplus.com.
About Jamieson Wellness
Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada’s #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit www.jamiesonwellness.com.
Investor and Media Contact:
Ruth Winker
Jamieson Wellness
416-960-0052
rwinker@jamiesonlabs.com
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…